...
首页> 外文期刊>Microbiology Research >Gliomas and brain lymphomas in HIV-1/AIDS patients: reflections from a 20-year follow up in Mexico and Brazil
【24h】

Gliomas and brain lymphomas in HIV-1/AIDS patients: reflections from a 20-year follow up in Mexico and Brazil

机译:HIV-1 / AIDS患者的神经胶质瘤和脑淋巴瘤:墨西哥和巴西20年随访的反思

获取原文
           

摘要

Opportunistic infections and invasive primary tumors represent major causes of morbidity and mortality in HIV-1-infected individuals. HIV-1 involvement of the central nervous system (CNS) affects nearly half of seropositive patients, being the primary CNS lymphoma (PCNSL) a hallmark neoplasia of this population. Interestingly, the incidence of other brain tumors (e.g. gliomas) is exceedingly rare in AIDS patients, and their co-morbidity has been limited to case reports. Here, we share our 20-year experience following brain tumors in HIV-1/AIDS patients from major referral hospitals in Mexico and Brazil. Additionally, we provide the most updated compilation of reported glioma cases in AIDS patients, with a thorough epidemiological analysis. Furthermore, we discuss HIV-1-driven mechanisms that would theoretically increase malignant transformation of glial cells; while offering newly reported explanations as to why protease inhibitors, key components of multi-drug anti-retroviral schemes, may be responsible for such a low co-incidence of gliomas in HIV-1 infected individuals.
机译:机会感染和侵袭性原发肿瘤是感染HIV-1的个体发病和死亡的主要原因。 HIV-1参与中枢神经系统(CNS)感染了将近一半的血清阳性患者,这是原发性CNS淋巴瘤(PCNSL)这一人群的标志性肿瘤。有趣的是,其他脑肿瘤(例如神经胶质瘤)的发病率在AIDS患者中极为罕见,并且其合并症仅限于病例报告。在这里,我们分享了我们在墨西哥和巴西主要转诊医院的HIV-1 / AIDS患者脑瘤治疗后的20年经验。此外,我们提供了艾滋病患者中报告的神经胶质瘤病例的最新汇编,并进行了全面的流行病学分析。此外,我们讨论了HIV-1驱动的机制,理论上将增加神经胶质细胞的恶性转化。同时提供了有关为什么蛋白酶抑制剂(多种药物抗逆转录病毒方案的关键组成部分)为何可能导致HIV-1感染个体中脑胶质瘤如此低的共发病率的最新报道的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号